Here are Thursday's biggest analyst calls: Nvidia, Costco, Apple, Snowflake, Meta, Nike, Disney, Airbnb & more

Why You Shouldn't Bet Against AnaptysBio (ANAB) Stock.

5 Stocks that Analysts Love in March 2024

Truist Financial Reaffirms Their Hold Rating on AnaptysBio (ANAB)

Industry Analysts Just Made A Stunning Upgrade To Their AnaptysBio, Inc. (NASDAQ:ANAB) Revenue Forecasts

What Makes AnaptysBio, Inc. (ANAB) a New Buy Stock

What Makes AnaptysBio, Inc. (ANAB) a New Buy Stock

Wall Street Analysts Believe AnaptysBio, Inc. (ANAB) Could Rally 69.62%: Here's is How to Trade

Wall Street Analysts Believe AnaptysBio, Inc. (ANAB) Could Rally 69.62%: Here's is How to Trade

Is ANI Pharmaceuticals (ANIP) Stock Outpacing Its Medical Peers This Year?

Analysts Offer Insights on Healthcare Companies: OptimizeRx (OPRX), AnaptysBio (ANAB) and REPRO-MED Systems (KRMD)

Analysts Offer Insights on Healthcare Companies: Incyte (INCY), AnaptysBio (ANAB) and iTeos Therapeutics (ITOS)

J.P. Morgan Reaffirms Their Hold Rating on AnaptysBio (ANAB)

Strong Buy Rating for AnaptysBio Based on Promising Pipeline and Financial Health

AnaptysBio, Inc. (ANAB) Reports Q4 Loss, Tops Revenue Estimates

AnaptysBio, Inc. (ANAB) Reports Q4 Loss, Tops Revenue Estimates

Anaptys Announces Fourth Quarter and Full Year 2023 Financial Results and Provides Business Update